RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @F_Lund_Johansen: A true milestone paper! https://t.co/kdrHoRUGiN
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @joely: News of significant innovation in COVID-19 testing!
News of significant innovation in COVID-19 testing!
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
A true milestone paper!
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @fjpinto1960: Good and bad news about tests and safe reopening. As it happens many times in medicine and health, there is more than just…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
¡Se ha publicado oficialmente! Nuestro ensayo serológico para evaluar si alguien tiene anticuerpos contra la proteína espiga del SARS-CoV-2. Esta prueba puede tener implicaciones significativas a medida que los estados comienzan a reabrirse.
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
“This is notable because it suggests that humans are serologically naive to SARS-CoV-2, compared with that of other respiratory viruses, such as influenza virus”. A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine https://t
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
Good and bad news about tests and safe reopening. As it happens many times in medicine and health, there is more than just one single measure to follow.
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
What is your take on the Return to Learn effort? https://t.co/UM8YaiMRL6
RT @LordGenome: A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine https://t.co/3URDSkaL6L
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine https://t.co/3URDSkaL6L
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @nataliepica: Pushing the science forward @florian_krammer and other Sinai virology team members - well done, as always https://t.co/wKQ…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
Great job you all!!
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
RT @FatimaAmanat: Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2…
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine https://t.co/ttHZBKOdYn
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
Its officially published! Our serological assay to test if someone has antibodies against the spike protein of SARS-CoV-2. This test can have significant implications as states begin to re-open https://t.co/sF2oYuEZ4l
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
A serological assay to detect SARS-CoV-2 seroconversion in humans https://t.co/G8a48dwMQ7
👏🏼👏🏼👏🏼
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @KindrachukJason: Great work to the Krammer lab!👏👏👏 https://t.co/XQEeq5gphs
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @nresearchnews: A @NatureMedicine paper presents a test that can detect the presence of antibodies to the SARS-CoV-2 virus in the blood…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
Éric Topol: La mauvaise nouvelle: les tests sont douteux pour faciliter la réouverture en toute sécurité https://t.co/XFZ8QaSSxo… @natashanyt La bonne nouvelle: ils s'améliorent, plus vite, moins cher, à la fois pour l'antigène / virus et les anticorps
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
ELISA to detect seroconversion in SARS-CoV-2 infection published in @NatureMedicine . This type of blood test will be essential to determine the infection fatality rate and seroprotection
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
Sometimes no antibody presence doesn't mean no virus presence.
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @ASCINA_NYC: Congrats, Dr. @florian_krammer and team! Excellent work! #COVID19 #AustrianScientistsinUS #Austria @ascina @OSTAustria_DC…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…